Zydus Introduces Generic Drug for Overactive Bladder in US Market

Zydus Lifesciences, an India-based pharmaceutical company, announced the availability of a generic treatment for overactive bladder in the US market. Zydus stated in a regulatory filing that the company has launched Mirabegron extended-release...

Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific

The Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific.

Mac-Chem Products (India) Pvt. Ltd’s Boisar facility Successfully Renews EU-GMP Certification

Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP certification for its manufacturing facility in Boisar.

IISc launches ‘Longevity India Initiative’ to pioneer ageing research in India

The Indian Institute of Science (IISc) announces the launch of the Longevity India Initiative, a project focused on efforts to extend human 'healthspan' and tackle ageing-related challenges

Takeda's Vedolizumab Secures US FDA Nod To Treat Crohn's Disease

Takeda, a leading pharmaceutical firm, declared that the US Food and Drug Administration (FDA) has granted approval for the subcutaneous administration of Entyvio (vedolizumab) as maintenance therapy in adults with moderately to severely active...

Evotec & Variant Bio Ink Pact To Discover Fibrosis Treatments

Evotec SE and Variant Bio, Inc. have agreed to work together to find the best treatment for fibrosis-related diseases. In organs like the liver and lungs, fibrosis is characterized by a marked and pathogenic accumulation of the tissue matrix and...

© 2024 India Pharma Outlook. All Rights Reserved.